Victor Davis Hanson offers lung cancer recovery update, unsure when he'll be 'back to near normal'

Hanson added that his bout of lung cancer has a "rare genetic/mutation profile" that tends to recur "about 40 percent of the time" with chemotherapy and immunotherapy largely ineffective in treating it.

However, he noted that they can offer "a 5-10% edge in stopping recurrence," and explained that he will do a cost-benefit analysis after some recovery to determine whether he will be receiving further treatment.

Though he was uncertain about when he would return to "near normal," Hanson remained optimistic that he would come back "as soon as possible."

"The bottom line is that I'm hoping to come back as soon as possible. But I don't know exactly when I'll be back to near normal. In the meantime, I hope to post things now and then on days when I feel better," Hanson wrote.

During last month's update, Fowler revealed that lymph nodes and peripheral samples around the tumor proved negative for malignancy and a preoperative full-body scan "did not show metastasis."